# The Combination of IVIG, Dexamethasone and a Megadose of PBSCs for Decreasing DSAs

> **NCT06471478** · — · COMPLETED · sponsor: **Hematology department of the 920th hospital** · enrollment: 11 (actual)

## Conditions studied

- Blood Disease

## Interventions

- **COMBINATION_PRODUCT:** intravenous immunoglobulin, dexamethasone and a megadose of peripheral-blood stem cell transfusion

## Key facts

- **NCT ID:** NCT06471478
- **Lead sponsor:** Hematology department of the 920th hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2021-10-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06471478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06471478, "The Combination of IVIG, Dexamethasone and a Megadose of PBSCs for Decreasing DSAs". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06471478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*